"Hallucinogens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.
Descriptor ID |
D006213
|
MeSH Number(s) |
D27.505.696.388 D27.505.954.427.700.372
|
Concept/Terms |
Hallucinogens- Hallucinogens
- Psychotomimetic Agents
- Agents, Psychotomimetic
- Hallucinogenic Agents
- Agents, Hallucinogenic
- Hallucinogenic Substances
- Substances, Hallucinogenic
- Psychedelics
- Psychedelic Agents
- Agents, Psychedelic
- Hallucinogenic Drugs
- Drugs, Hallucinogenic
|
Below are MeSH descriptors whose meaning is more general than "Hallucinogens".
Below are MeSH descriptors whose meaning is more specific than "Hallucinogens".
This graph shows the total number of publications written about "Hallucinogens" by people in this website by year, and whether "Hallucinogens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2006 | 4 | 0 | 4 |
2007 | 2 | 1 | 3 |
2009 | 1 | 2 | 3 |
2015 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 2 | 3 |
2020 | 1 | 1 | 2 |
2022 | 3 | 0 | 3 |
2023 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hallucinogens" by people in Profiles.
-
Anxiety sensitivity reduction-smoking cessation intervention among individuals who engage in dual cigarette and cannabis use: A secondary analysis. J Subst Use Addict Treat. 2024 01; 156:209211.
-
Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico. Am J Drug Alcohol Abuse. 2023 09 03; 49(5):587-596.
-
Psychedelics. J Psychiatr Pract. 2023 09 01; 29(5):343-344.
-
Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries. J Palliat Med. 2023 11; 26(11):1482-1487.
-
Pressing regulatory challenges for psychedelic medicine. Science. 2023 04 28; 380(6643):347-350.
-
Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans. Mil Psychol. 2024 Mar-Apr; 36(2):184-191.
-
Anxiety sensitivity and cigarette use on cannabis use problems, perceived barriers for cannabis cessation, and self-efficacy for quitting among adults with cannabis use disorder. Addict Behav. 2023 02; 137:107509.
-
Letter to the Editor: Prevalence of Self-Reported Cannabis Use among Patients at a Supportive Care Clinic in a Tertiary Cancer Center. J Palliat Med. 2022 08; 25(8):1176-1178.
-
Trazodone Prolonged-Release Monotherapy in Cannabis Dependent Patients during Lockdown Due to COVID-19 Pandemic: A Case Series. Int J Environ Res Public Health. 2022 06 16; 19(12).
-
Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine. Expert Opin Investig Drugs. 2022 02; 31(2):133-137.